Price List for Heart Disease Treatment in China
|

China Heart Disease Treatment Price List

ByHeart Disease Q&A

China Heart Disease Treatment Price List: 2026 Self-Payment Guide for Foreigners

With the implementation of China’s national bulk procurement policy for medical consumables, the out-of-pocket costs for heart disease treatment in China have been significantly reduced. This guide compiles the latest 2025 data, covering four core types of heart disease—coronary artery disease, valvular heart disease, arrhythmia, and congenital heart disease. It exclusively presents the actual out-of-pocket expenses for foreigners seeking medical care in China, providing accurate references for medical planning (Note: All prices are in RMB, including surgical fees, consumable costs, hospitalization fees, and basic postoperative care fees; long-term medication and complication management costs are not included. Out-of-pocket amounts may vary slightly based on consumable choices and hospital levels, with the following being mainstream market ranges).

I. Out-of-Pocket Costs for Coronary Artery Disease Treatment

Treatment MethodTotal Cost Range (RMB)Key Consumables Price DetailsForeigners’ Out-of-Pocket Range (RMB)
Single-vessel Stenting30,000-45,000Bulk-procured stents (domestic/imported): ≤1,000 RMB/piece30,000-45,000
Multi-vessel Stenting50,000-80,000Stents + auxiliary consumables (balloons, etc.): ≤3,000 RMB/set50,000-80,000
Drug-eluting Balloon Angioplasty (Interventional No-Implant)25,000-35,000Bulk-procured drug-eluting balloons: ≤8,000 RMB/piece (Winning products of the 6th national bulk procurement)25,000-35,000
Traditional Open-chest CABG80,000-150,000Graft materials + surgical consumables: 10,000-20,000 RMB80,000-150,000
Minimally Invasive Off-pump CABG120,000-200,000Minimally invasive instruments + consumables: 15,000-25,000 RMB120,000-200,000
Conservative Drug Therapy (Annual Cost)3,000-8,000Statins + antiplatelet drugs: 3,000-8,000 RMB/year3,000-8,000
  • Cost-Saving Tips:
  1. Prioritize bulk-procured stents (used in over 90% of clinical cases), which have the same 2-year postoperative efficacy as non-bulk-procured products and can save over 5,000 RMB per stent;
  2. The total cost of stenting in secondary hospitals is 10%-15% lower than that in Grade A tertiary hospitals. Patients with acute myocardial infarction can receive treatment locally to reduce transportation costs;
  3. Patients with complex lesions can apply for advanced technology subsidies, enabling free access to additional items such as intravascular imaging and rotational atherectomy.

II. Out-of-Pocket Costs for Valvular Heart Disease Treatment

Treatment MethodTotal Cost Range (RMB)Key Consumables Price DetailsForeigners’ Out-of-Pocket Range (RMB)
Mitral Valve Repair100,000-180,000Repair instrument set: 15,000-30,000 RMB100,000-180,000
Aortic Valve Replacement (Mechanical Valve)120,000-200,000Domestic mechanical valve: 10,000-15,000 RMB; Imported mechanical valve: 20,000-30,000 RMB120,000-200,000
Aortic Valve Replacement (Biological Valve)150,000-250,000Domestic biological valve: 20,000-30,000 RMB; Imported biological valve: 40,000-60,000 RMB150,000-250,000
Transcatheter Aortic Valve Replacement (TAVR)250,000-400,000Domestic TAVR consumables: 80,000-120,000 RMB; Imported TAVR consumables: 150,000-200,000 RMB250,000-400,000
Transcatheter Mitral Valve Repair (MitraClip)300,000-500,000Domestic repair system: 100,000-150,000 RMB300,000-500,000
  • Cost-Saving Tips:
  1. Domestic valves are approximately 50% cheaper than imported ones with similar service life, enabling savings of 10,000-30,000 RMB in out-of-pocket costs;
  2. Patients over 65 years old undergoing TAVR treatment can apply for special subsidies, reducing out-of-pocket expenses by an additional 10%-20%;
  3. Some hospitals implement a disease-specific payment model, offering 10%-15% discounts on valve consumables for direct self-paying patients.

III. Out-of-Pocket Costs for Arrhythmia Treatment

Treatment MethodTotal Cost Range (RMB)Key Consumables Price DetailsForeigners’ Out-of-Pocket Range (RMB)
Single-chamber Pacemaker Implantation20,000-30,000Bulk-procured single-chamber pacemaker: 15,000-20,000 RMB20,000-30,000
Dual-chamber Pacemaker Implantation40,000-80,000Bulk-procured dual-chamber pacemaker: 30,000-50,000 RMB40,000-80,000
Triple-chamber Pacemaker (CRT) Implantation70,000-140,000Bulk-procured CRT pacemaker: 50,000-90,000 RMB70,000-140,000
ICD Implantation80,000-150,000Bulk-procured ICD: 60,000-100,000 RMB80,000-150,000
Atrial Fibrillation Radiofrequency Ablation60,000-100,000Ablation catheters + 3D mapping system: 20,000-40,000 RMB60,000-100,000
  • Cost-Saving Tips:
  1. Bulk-procured pacemakers are 40%-60% cheaper than non-bulk-procured models, with the cost of dual-chamber pacemakers controllable within the 40,000-60,000 RMB range;
  2. Choosing domestic equipment instead of high-end imported products can save 30%-50% of costs while maintaining consistent treatment effects;
  3. Routine pacemaker implantation is available in county-level hospitals, with costs 2,000-5,000 RMB lower than in Grade A tertiary hospitals.

IV. Out-of-Pocket Costs for Congenital Heart Disease Treatment

Treatment MethodTotal Cost Range (RMB)Key Consumables Price DetailsForeigners’ Out-of-Pocket Range (RMB)
Minimally Invasive Atrial Septal Defect Closure30,000-60,000Domestic occluder: 5,000-10,000 RMB30,000-60,000
Ventricular Septal Defect Repair60,000-120,000Repair materials + consumables: 8,000-15,000 RMB60,000-120,000
Patent Ductus Arteriosus Ligation40,000-80,000Ligation instruments: 3,000-8,000 RMB40,000-80,000
Tetralogy of Fallot Radical Correction150,000-300,000Cardiopulmonary bypass + surgical consumables: 30,000-50,000 RMB150,000-300,000
Total Anomalous Pulmonary Venous Connection Correction200,000-400,000Correction instruments + consumables: 40,000-60,000 RMB200,000-400,000
  • Cost-Saving Tips:
  1. Choose domestic occluders and repair materials, which are 3,000-8,000 RMB cheaper than imported alternatives;
  2. Top-tier children’s hospitals (e.g., Beijing Children’s Hospital) offer package prices for pediatric congenital heart disease surgeries, reducing overall costs by 5%-10%;
  3. Long-term follow-up examinations (e.g., echocardiography) can be conducted at community hospitals, with fees 30%-50% lower than those at specialized hospitals.

V. Important Notes for Cost Control

  1. Prioritize bulk-procured consumables: National bulk procurement has drastically reduced the prices of core consumables such as cardiac stents, pacemakers, and artificial valves—this is the key to cost control;
  2. Hospital selection impacts costs: Secondary and county-level hospitals charge 10%-20% less for common heart surgeries than Grade A tertiary hospitals, while maintaining comparable medical standards;
  3. Beware of additional fees: Imported consumables and high-end equipment are more expensive; costs for complex cases (e.g., combined with heart failure or renal failure) may increase by 50%-100%;
  4. Confirm costs in advance: Request a detailed cost breakdown from the hospital before surgery, including consumable fees, surgical fees, and hospitalization costs, to avoid unexpected expenses.

VI. Summary

In 2025, heart disease treatment in China offers exceptional cost-effectiveness, with out-of-pocket expenses only 1/5 to 1/3 of those in the United States and Europe. For foreigners, the core cost-saving strategies are to choose bulk-procured domestic consumables, select hospitals of appropriate levels based on the complexity of their condition, and confirm cost details in advance.

Top-tier hospitals such as Fuwai Hospital and Anzhen Hospital provide world-class medical technology for complex cases, while secondary and county-level hospitals are cost-effective options for routine surgeries. With clear price transparency and mature medical services, China has become a preferred destination for foreigners seeking high-quality, affordable heart disease treatment.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *